Thirty-eight individuals (mean age: 34.8 years old) participating in a 3-month yoga and meditation retreat were assessed before and after the intervention for psychometric measures, brain derived neurotrophic factor (BDNF), circadian salivary cortisol levels, and pro- and anti-inflammatory cytokines. Participation in the retreat was found to be associated with decreases in self-reported anxiety and depression as well as increases in mindfulness. As hypothesized, increases in the plasma levels of BDNF and increases in the magnitude of the cortisol awakening response (CAR) were also observed. The normalized change in BDNF levels was inversely correlated with BSI-18 anxiety scores at both the pre-retreat (r = 0.40, p < 0.05) and post-retreat (r = 0.52, p < 0.005) such that those with greater anxiety scores tended to exhibit smaller pre- to post-retreat increases in plasma BDNF levels. In line with a hypothesized decrease in inflammatory processes resulting from the yoga and meditation practices, we found that the plasma level of the anti-inflammatory cytokine Interleukin-10 was increased and the pro-inflammatory cytokine Interleukin-12 was reduced after the retreat. Contrary to our initial hypotheses, plasma levels of other pro-inflammatory cytokines, including Interferon Gamma (IFN-γ), Tumor Necrosis Factor (TNF-α), Interleukin-1β (IL-1β), Interleukin-6 (IL-6), and Interleukin-8 (IL-8) were increased after the retreat. Given evidence from previous studies of the positive effects of meditative practices on mental fitness, autonomic homeostasis and inflammatory status, we hypothesize that these findings are related to the meditative practices throughout the retreat; however, some of the observed changes may also be related to other aspects of the retreat such as physical exercise-related components of the yoga practice and diet. We hypothesize that the patterns of change observed here reflect mind-body integration and well-being. The increased BDNF levels observed is a potential mediator between meditative practices and brain health, the increased CAR is likely a reflection of increased dynamic physiological arousal, and the relationship of the dual enhancement of pro- and anti-inflammatory cytokine changes to healthy immunologic functioning is discussed.

No abstract

Mu Rhythm Synchrony Neurofeedback (MRS-NFB) has shown promise in improving electrophysiological and behavioral deficits in autism spectrum disorder (ASD). Heart rate variability biofeedback (HRV-BFB), a method for improving self-regulation of the autonomic nervous system (ANS), has yet to be tested as a clinical intervention for ASD. This study evaluated the impact of HRV-BFB on symptoms of ASD; and whether a combined HRV-BFB + MRS-NFB intervention would be more efficacious than HRV-BFB alone. Fifteen children with a verified diagnosis of ASD completed the study. Participants were assigned to either an HRV-BFB group (Group 1) or a combined HRV-BFB + MRS-NFB group (Group 2). All children underwent pre-and postassessments of electroencephalography (EEG), heart rate variability (HRV), and parent-reported behaviors. No significant between-groups differences were observed on any parent-reported behaviors. Group 1 showed significant pre-post improvements in emotion regulation and social behavior, while Group 2 showed significant pre-post improvements in emotional lability and autistic behaviors. Group 2 also showed significant improvements in RMSSD and lnHF (vagal tone) indices of HRV over time, while Group 1 displayed no significant changes in HRV over time. Group 1 showed an increase in mu suppression posttraining, and Group 2 showed a reduction in mu suppression posttraining. The results suggest that HRV-BFB, alone or in combination with MRS-NFB, may improve behavioral features of autism. A combined approach may be more efficacious in enhancing HRV, while the implications of each approach on mu suppression are mixed. Neurovisceral approaches that teach self-regulation offer a novel treatment avenue for ASD.

No abstract